Karo Pharma (Cancer Project KB9520)

Business Data, Corporate Office and Headquarter Address

About

Karo Pharma (Cancer Project KB9520) is Buildings and Property in Sweden that focus on estrogen receptor cancer drug business. They cover business area such as cancer treatment, various type.

Business Type

Buildings and Property

Country

Sweden

Founded

-

Company Focus

Estrogen Receptor Cancer Drug

Website

-

Corporate Office and Headquarter Office address:

Nybrokajen 7
Stockholm
Sweden

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

cancer treatmentvarious type

* We use standard office opening hours in near Karo Pharma (Cancer Project KB9520)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Karo Pharma (Cancer Project KB9520) Frequently Asked Questions

What or who is Karo Pharma (Cancer Project KB9520)?

Karo Pharma (Cancer Project KB9520) is Buildings and Property business from Sweden that founded in - ( years old in ), Karo Pharma (Cancer Project KB9520) business is focusing on Estrogen Receptor Cancer Drug.

Where is Karo Pharma (Cancer Project KB9520) headquarter and corporate office address?

Karo Pharma (Cancer Project KB9520) headquarter office and corporate office address is located in Nybrokajen 7 Stockholm Sweden.

Where is Karo Pharma (Cancer Project KB9520) country origins?

Karo Pharma (Cancer Project KB9520) was founded in Sweden.

What is Estrogen Receptor Cancer Drug business focus on?

In , Karo Pharma (Cancer Project KB9520) is currently focus on estrogen receptor cancer drug sector.

Estrogen Receptor Cancer Drug Business Interest from Google Trend

Above is snippet of Google Trends for "estrogen receptor cancer drug" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Karo Pharma (Cancer Project KB9520), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.